Schizophrenia

The Pharmacy Times® Schizophrenia Resource Center is a comprehensive resource for clinical news and expert insights on treatments for schizophrenia.

Latest News

Schizophrenia disorder and psychiatric disease or mental health as a psychiatry and psychology concept for human abnormal personality behavior and mood illness
Improving Schizophrenia Outcomes: The Role of Long-Acting Injectables and Medication Adherence

October 14th 2024

Offering pharmacy professionals insights into the benefits, importance and challenges associated with switching patients to long-acting injectables to treat schizophrenia.

Schizophrenia FDA Approval | Image Credit: Aquir - stock.adobe.com
FDA Approves Cobenfy, Previously KarXT, for Treatment of Schizophrenia

September 27th 2024

FDA Approval | Image Credit: wladimir1804 - stock.adobe.com
FDA Approves Long-Acting Injectable Paliperidone for Schizophrenia Treatment

July 29th 2024

If dreams come true, can nightmares too. Shot of a young man sitting in the corner of a dark room with a scary figure on the wall - Image credit: Siphosethu Fanti/peopleimages.com | stock.adobe.com
Study: Probiotic with Vitamin D Supplements Could Aid Individuals with Schizophrenia

April 30th 2024

Mental health conditions, schizophrenia diagnosis and treatment with antipsychotic medication and psychotherapy. | Image Credit: Olivier Le Moal - stock.adobe.com
More Research Needed for Treatment of Clozapine-Resistant Schizophrenia

April 8th 2024

Video Interviews

More News